Trial · NCT03726216
Xydalba Utilization Registry in France
NCT03726216, Completed, Correvio International Sarl
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Xydalba Utilization Registry in France. Trials, record NCT03726216. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03726216
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Xydalba Utilization Registry in France
- NCT number
- NCT03726216
- Status
- Completed
- Enrollment
- 151 participants, actual
- Lead sponsor
- Correvio International Sarl
- Conditions
- Bacterial Infections
- Interventions
- Xydalba
- First posted
- 2018-10-31
- Last updated
- 2021-07-20
Source ClinicalTrials.gov
Registered outcomes13
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Clinical response | 30 days | Prevalence of ABSSSI and other primary diagnoses among patients who received Xydalba (dalbavancin) as treatment for this primary diagnosis |
| Secondary | Clinical response by diagnosis | 30 days | Clinical response by cured, improved, failure, non-evaluable, worsening or other (non-clinically evaluable) |
| Secondary | Clinical response by diagnosis | 30 days | Clinical response by diagnosis (ABSSSI, Gram-positive bacteremia, other associated diagnosis) |
| Secondary | Time from Xydalba treatment onset to clinical response | 30 days | |
| Secondary | Adverse Events, Adverse Drug Reactions and Special Situations | 30 days | |
| Other | Xydalba Treatment dose(s) | 30 days | Dose(s) of Xydalba in mg per infusion |
| Other | Number of Xydalba Infusions | 30 days | number of Infusions given |
| Other | Length of Xydalba Infusions | 30 days | length of Infusions in minutes |
| Other | Days of Xydalba treatment | 30 days | number of Days of treatment |
| Other | Percentage of monotherapy vs. concurrent therapy | 30 days | % of cases for which Xydalba is given as monotherapy and % of cases for which Xydalba is given as concurrent therapy |
1 to 10 of 13Source ClinicalTrials.gov
See all 13 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT03726216
GET https://conductscience.org/api/trials/v1/NCT03726216/registered